Bond Bristol Myers-Squibb 2.95% ( US110122DW58 ) in USD
| Issuer | Bristol Myers-Squibb |
| Market price | |
| Country | United States
|
| ISIN code |
US110122DW58 ( in USD )
|
| Interest rate | 2.95% per year ( payment 2 times a year) |
| Maturity | 15/03/2032 |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 2 000 000 000 USD |
| Cusip | 110122DW5 |
| Standard & Poor's ( S&P ) rating | A+ ( Upper medium grade - Investment-grade ) |
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) |
| Next Coupon | 15/03/2026 ( In 36 days ) |
| Detailed description |
Bristol Myers Squibb is a global biopharmaceutical company engaged in the research, development, and marketing of innovative medicines and biotherapeutics across various therapeutic areas, including oncology, cardiovascular disease, immunology, and fibrosis. Bristol Myers Squibb issued a USD 2,000,000,000 bond (CUSIP: 110122DW5, ISIN: US110122DW58) maturing on March 15, 2032, with a 2.95% coupon rate, paying semi-annually, currently trading at 100% of par, rated A+ by S&P and A2 by Moody's, with a minimum purchase amount of 2,000. |
Français
Italiano
United States